Evidence map›Paper›PMID 24196444›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Mal3, the Schizosaccharomyces pombe homolog of EB1, is required for karyogamy and for promoting oscillatory nuclear movement during meiosis.

Silvia Polakova, Zsigmond Benko, Lijuan Zhang, Juraj Gregan

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Silvia PolakovaMax F. Perutz Laboratories; Department of Chromosome Biology; University of Vienna; Vienna, Austria.
Zsigmond BenkoMax F. Perutz Laboratories; Department of Chromosome Biology; University of Vienna; Vienna, Austria.
Lijuan ZhangMax F. Perutz Laboratories; Department of Chromosome Biology; University of Vienna; Vienna, Austria.
Juraj GreganMax F. Perutz Laboratories; Department of Chromosome Biology; University of Vienna; Vienna, Austria; Department of Genetics; Comenius University; Bratislava, Slovak Republic.
Max Perutz Labs · ATUniversity of Vienna · AT

Funding

Austrian Science Fund FWF P 21437Austrian Science Fund FWF P 23609
6 · The paper itself

Abstract

Two successive rounds of chromosome segregation following a single round of DNA replication enable the production of haploid gametes during meiosis. In the fission yeast Schizosaccharomyces pombe, karyogamy is the process where the nuclei from 2 haploid cells fuse to create a diploid nucleus, which then undergoes meiosis to produce 4 haploid spores. By screening a collection of S. pombe deletion strains, we found that the deletion of 2 genes, mal3 and mto1, leads to the production of asci containing up to 8 spores. Here, we show that Mal3, the fission yeast member of the EB1 family of conserved microtubule plus-end tracking proteins, is required for karyogamy, oscillatory nuclear movement, and proper segregation of chromosomes during meiosis. In the absence of Mal3, meiosis frequently initiates before the completion of karyogamy, thus producing up to 8 nuclei in a single ascus. Our results provide new evidence that fission yeast can initiate meiosis prior to completing karyogamy.

Indexed as

Cell NucleusChromosome SegregationDNA ReplicationMeiosisMicrotubule-Associated ProteinsMicrotubulesSchizosaccharomyces pombe ProteinsMal3 protein, S pombeMicrotubule-Associated ProteinsSchizosaccharomyces pombe Proteinschromosome segregationfission yeastkaryogamymeiosismicrotubules

Identifiers

PMID24196444
PMCPMC3925738
OpenAlexW2072898167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.